FergusonMchugh MaryLynn 4
4 · PROCTER & GAMBLE Co · Filed Aug 5, 2021
Insider Transaction Report
Form 4
FergusonMchugh MaryLynn
Group President - Europe
Transactions
- Award
Restricted Stock Units
2021-05-17+116.453→ 2,212.942 total→ Common Stock (116.453 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2021-08-04−49,899→ 0 totalExercise: $78.66From: 2017-02-28Exp: 2024-02-28→ Common Stock (49,899 underlying) - Exercise/Conversion
Common Stock
2021-08-04$78.66/sh+49,899$3,925,055→ 170,519.837 total - Sale
Common Stock
2021-08-04$143.32/sh−49,899$7,151,475→ 120,620.837 total
Holdings
- 25,160.964(indirect: By Trust)
Common Stock
- 28,355.953(indirect: By Trust)
Common Stock
- 134.993(indirect: By Spouse)
Common Stock
Footnotes (5)
- [F1]Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.
- [F2]Weighted average price of the shares sold. The price range was $143.25 to $143.42. Full information regarding the number of shares sold at each separate price available upon request.
- [F3]Reflects adjustment to PST through June 30, 2021.
- [F4]Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
- [F5]These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.